Hinder handing the message -- stopping tumors from creating new blood vessels

December 14, 2020

Researchers from Tokyo Medical and Dental University (TMDU) identify a novel role for a protein, vasohibin-1, in preventing cancer cells from spreading

Tokyo, Japan - Cancer often becomes more difficult to treat and has a poorer prognosis when it spreads throughout the body. This process, called metastasis, is promoted by various cellular events not only become uncontrolled via mutations in cancerous cells, but also by the effects from many types of cells surrounding cancer. One such event is tumor angiogenesis - the abnormal development of new blood vessels in near solid cancers, causing cancer gets worth. Now, researchers at Tokyo Medical and Dental University (TMDU) have recently discovered an unique inhibitory function of a protein that may help suppress the formation of these tumor vessels in cancer tumors.

In a report published in Angiogenesis, a group of researchers from TMDU elucidated the mechanism by which the protein vasohibin-1, also known as VASH1, can block the vasucular-composing cells from receiving signals and messages from surrounding cancer cells or cancer microenvironment to generate new vessels, thus may reducing potential metastasis. It was previously unknown how VASH1 achieves block of creating new vessel leading to the anti-cancer outcome.

In earlier studies, this group showed that VASH1 can reduce the movement activity of endothelial cells - the cells that form blood vessels. They also examined how VASH1 affects microtubules, which are cellular tubelike structures that sometimes serve as a set of molecular railroad tracks on which different components can travel around the cell. Because of the signal received molecules are also transported on microtubules, alterations to microtubule condition can modulate certain signals from being brought into the cell from its outside environment and change the cell's behavior. Building on their previous findings, the researchers at TMDU further investigated the ability of VASH1 to influence endothelial cells, microtubules, and the suppression of angiogenesis.

"Angiogenesis is an extremely important process that allows tumor cells to obtain oxygen and nutrients from blood flow to promote tumor growth," says lead author of the study Miho Kobayashi. "We knew that VASH1 can inhibit this process by affecting endothelial cells, but it was not clear how exactly this protein was able to do so."

To address their questions, the researchers looked for a specific change to microtubule condition, called detyrosination, and examined how VASH1 affects the transport of important signal-received molecules into the cell along microtubules. They ascertained the particular role of VASH1 in these processes by repeating their experiments with a VASH1 mutant or a VASH1 specific inhibitor that cannot change the microtubules.

"We found that VASH1 could mediate detyrosination of microtubules in vascular," describes Yasufumi Sato from Tohoku University, research collaborator. "This function of the protein is ultimately how it can block angiogenesis."

This condition change prevents certain external signals from being brought into the cell and travel along the microtubules.

"Specific outside messages enter the cell and induce changes that cause it to accelerate angiogenesis," says Kobayashi. "Yet, VASH1 activity acts like a roadblock that stops them from reaching their destination."

With a greater understanding of angiogenesis make increase ideas of how to suppress cancer growth and spread. This study provides vital knowledge that will support the development of new strategies for the treatment of cancer.
-end-
The article, "Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors," was published in Angiogenesis at DOI: 10.1007/s10456-020-09754-6

Tokyo Medical and Dental University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.